SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-14-197009
Filing Date
2014-05-13
Accepted
2014-05-13 16:07:39
Documents
9
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d724186d10ka.htm 10-K/A 26506
2 EX-10.28 d724186dex1028.htm EX-10.28 134383
3 EX-10.29 d724186dex1029.htm EX-10.29 359983
4 EX-31.1 d724186dex311.htm EX-31.1 3220
5 EX-31.2 d724186dex312.htm EX-31.2 3219
6 GRAPHIC g724186g05c15.jpg GRAPHIC 2824
7 GRAPHIC g724186g06j18.jpg GRAPHIC 3686
8 GRAPHIC g724186g31g99.jpg GRAPHIC 27444
9 GRAPHIC g724186g61u84.jpg GRAPHIC 38677
  Complete submission text file 0001193125-14-197009.txt   628964
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35068 | Film No.: 14837368
SIC: 2834 Pharmaceutical Preparations